Browse News
Filter News
Found 2 articles
-
Closing out the month of May, plenty of companies presented or announced clinical trial updates and news. Here’s a look.
-
Anji Pharma Completes Patient Enrollment in Phase 2 Study of Pradigastat in Functional Constipation
5/18/2022
Anji Pharma , an emerging global medicines company, today announced it has completed enrollment in its Phase 2 proof of concept study of pradigastat (ANJ908), a diacylglycerol acyltransferase 1 (DGAT1) inhibitor, in patients with functional constipation.